These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10501230)

  • 1. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles.
    Diminsky D; Moav N; Gorecki M; Barenholz Y
    Vaccine; 1999 Aug; 18(1-2):3-17. PubMed ID: 10501230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars.
    Tonnis WF; Amorij JP; Vreeman MA; Frijlink HW; Kersten GF; Hinrichs WL
    Eur J Pharm Sci; 2014 May; 55():36-45. PubMed ID: 24468629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity.
    Diminsky D; Schirmbeck R; Reimann J; Barenholz Y
    Vaccine; 1997; 15(6-7):637-47. PubMed ID: 9178464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance.
    Sacherl J; Kosinska AD; Kemter K; Kächele M; Laumen SC; Kerth HA; Öz EA; Wolff LS; Su J; Essbauer S; Sutter G; Scholz M; Singethan K; Altrichter J; Protzer U
    JHEP Rep; 2023 Feb; 5(2):100603. PubMed ID: 36714793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis-B surface antigen (HBsAg) powder formulation: process and stability assessment.
    Maa YF; Ameri M; Shu C; Zuleger CL; Che J; Osorio JE; Payne LG; Chen D
    Curr Drug Deliv; 2007 Jan; 4(1):57-67. PubMed ID: 17269918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B.
    Czyż M; Dembczyński R; Marecik R; Wojas-Turek J; Milczarek M; Pajtasz-Piasecka E; Wietrzyk J; Pniewski T
    Biomed Res Int; 2014; 2014():485689. PubMed ID: 25371900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of S-HBsAg in long-term stored lyophilised plant tissue.
    Czyż M; Dembczyński R; Marecik R; Pniewski T
    Biologicals; 2016 Mar; 44(2):69-72. PubMed ID: 26774819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic and physicochemical characterization of Hepatitis B surface protein under extreme temperature and pH conditions.
    Lopes JLS; Oliveira DCA; Utescher CLA; Quintilio W; Tenório ECN; Oliveira CLP; Fantini MCA; Rasmussen MK; Bordallo HN; Sant'Anna OA; Botosso VF
    Vaccine; 2019 Oct; 37(43):6415-6425. PubMed ID: 31519445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetrical flow field-flow fractionation coupled with multi-angle laser light scattering for stability comparison of virus-like particles in different solution environments.
    Chen Y; Zhang Y; Zhou Y; Luo J; Su Z
    Vaccine; 2016 Jun; 34(27):3164-3170. PubMed ID: 27129428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
    Maa YF; Zhao L; Payne LG; Chen D
    J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unimpaired immunogenicity of yeast-expressed hepatitis B surface antigen stored at elevated temperatures.
    Shen Z; Rao Y; Tao S; Luo M; Ming L; Liu J; Pan S; Xie Y
    Acta Biochim Biophys Sin (Shanghai); 2016 Dec; 48(12):1094-1100. PubMed ID: 27827798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
    Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature.
    Nedergaard H; Vestergaard S; Jensen PT; Kristiansen MW; Jensen MB; Ostergaard PB; Norsell T; Bjerre J
    Clin Ther; 2008 Jul; 30(7):1309-15. PubMed ID: 18691990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
    Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
    J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein.
    Yamada T; Iwabuki H; Kanno T; Tanaka H; Kawai T; Fukuda H; Kondo A; Seno M; Tanizawa K; Kuroda S
    Vaccine; 2001 Apr; 19(23-24):3154-63. PubMed ID: 11312011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical properties of recombinant hepatitis B surface antigen expressed in mammalian cell (C127).
    Lee YS; Kim BK; Choi EC
    Arch Pharm Res; 1998 Oct; 21(5):521-6. PubMed ID: 9875488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
    Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
    Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines.
    Shouval D; Ilan Y; Adler R; Deepen R; Panet A; Even-Chen Z; Gorecki M; Gerlich WH
    Vaccine; 1994 Nov; 12(15):1453-9. PubMed ID: 7533967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties.
    Gurramkonda C; Zahid M; Nemani SK; Adnan A; Gudi SK; Khanna N; Ebensen T; Lünsdorf H; Guzmán CA; Rinas U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():104-11. PubMed ID: 24141044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the immunogenicity of liposomal hepatitis B surface antigen (HBsAg) by controlling its delivery from polymeric microspheres.
    Machluf M; Apte RN; Regev O; Cohen S
    J Pharm Sci; 2000 Dec; 89(12):1550-7. PubMed ID: 11042602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.